Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
叶酸药物基因组学和非典型抗精神病药代谢副作用的风险
基本信息
- 批准号:8213443
- 负责人:
- 金额:$ 33.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2013-07-21
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAllelesAttenuatedCardiovascular DiseasesCardiovascular systemClinical ResearchCommunitiesDataDevelopmentDiabetes MellitusDietDietary FactorsEnvironmentEpidemicFolateFunctional disorderFundingFutureGeneral PopulationGeneticGenotypeGoalsHealthHealth ExpendituresHomocysteineHomocystineIncidenceInsulin ResistanceIntakeInvestigationK-Series Research Career ProgramsLaboratoriesLearningLigaseLinkMeasuresMediatingMedicineMental HealthMental disordersMetabolicMetabolic PathwayMetabolic syndromeMetabolismMethionineMethylenetetrahydrofolate reductase (NADPH)Morbidity - disease rateNational Institute of Mental HealthNon-Insulin-Dependent Diabetes MellitusObesityOther GeneticsOxidoreductasePatientsPharmacogeneticsPharmacogenomicsPharmacy facilityPhysiciansPopulationProxyQuality of lifeRecording of previous eventsResearchRiskRisk FactorsRoleSchizophreniaSyndromeTherapeutic UsesUnited States National Institutes of HealthVariantVascular DiseasesWeight GainWorkattenuationatypical antipsychoticbasebrachial arterycardiovascular disorder riskclinical practicecollegeexperiencefolic acid metabolismgenetic varianthealth organizationinnovationlifestyle factorsmeetingsopen labelsudden cardiac deathtoolwaist circumference
项目摘要
DESCRIPTION (provided by applicant): In schizophrenia patients treated with atypical antipsychotics (AAPs), metabolic syndrome and insulin resistance/diabetes mellitus (DM) incidence is two to four fold higher than the general population. Aberrant folate metabolism is linked to a greater risk for CVD, DM, and endothelial dysfunction. Specifically the methylenetetrahydrofolate reductase (MTHFR) 677C/T variant has been associated with a 14% increase in CVD risk in the general population and a 36% greater risk for schizophrenia, although these relationships are highly dependent on dietary folate intake. This variant has not been investigated with metabolic syndrome and DM seen in schizophrenia. Our research group is the first to investigate the relationship between MTHFR, metabolic syndrome, and insulin resistance in schizophrenia. The objective of this application is to better understand the interplay of folate pharmacogenetics and diet and lifestyle factors on developing AAP-associated metabolic complications; metabolic syndrome, and insulin resistance. Additionally we will systematically measure endothelial functioning in this population and determine the role of supplemental folate administration on attenuation of these metabolic consequences. Our primary hypothesis is that MTHFR confounds inadequate folate intake and confers a greater risk for insulin resistance from AAP use. This contributes to the metabolic syndrome, endothelial dysfunction, and CVD in this population. We have formulated this hypothesis based on our pilot data (from a NIMH Career Development Award) showing a relationship between the MTHFR T allele and a greater risk for metabolic syndrome and insulin resistance in schizophrenia patients receiving AAPs. Our rationale is that the MTHFR T allele combined with inadequate diet, increases insulin resistance risk with AAP use, contributing to the metabolic syndrome, which facilitates endothelial dysfunction, leading to CVD. Thus, supplemental folate may be a realistic treatment option to reduce AAP-associated cardiovascular complications. Successful completion of this study would fundamentally advance schizophrenia treatment as we learn more about genetic, dietary, and lifestyle factors that relate to AAP-associated metabolic complications, as well as measuring the incidence of endothelial dysfunction in this population, and identifying potential ameliorating factors such as supplemental folate in an effort to attenuate the overall cardiovascular burden associated with AAP use. PUBLIC HEALTH RELEVANCE: This proposal will help clinicians gain a better understanding of how genetics, dietary and lifestyle factors interact to place patients with schizophrenia at increased risk for metabolic syndrome, insulin resistance, and endothelial dysfunction from atypical antipsychotic use.
描述(由申请方提供):在接受非典型抗精神病药(AAP)治疗的精神分裂症患者中,代谢综合征和胰岛素抵抗/糖尿病(DM)的发生率比一般人群高2 - 4倍。叶酸代谢异常与CVD、DM和内皮功能障碍的风险增加有关。特别是亚甲基四氢叶酸还原酶(MTHFR)677 C/T变异与一般人群CVD风险增加14%和精神分裂症风险增加36%相关,尽管这些关系高度依赖于膳食叶酸摄入量。尚未对精神分裂症中出现的代谢综合征和DM进行研究。本课题组首次对精神分裂症患者MTHFR、代谢综合征和胰岛素抵抗的关系进行了研究。本申请的目的是更好地了解叶酸药物遗传学和饮食和生活方式因素对AAP相关代谢并发症、代谢综合征和胰岛素抵抗的相互作用。此外,我们还将系统地测量这一人群的内皮功能,并确定补充叶酸对减轻这些代谢后果的作用。我们的主要假设是,MTHFR混淆叶酸摄入不足,并赋予AAP使用胰岛素抵抗的风险更大。这导致了该人群中的代谢综合征、内皮功能障碍和CVD。我们已经制定了这一假设的基础上,我们的试点数据(从NIMH职业发展奖)显示MTHFR T等位基因和接受AAP的精神分裂症患者的代谢综合征和胰岛素抵抗的风险更大之间的关系。我们的理论依据是MTHFR T等位基因与饮食不足相结合,增加了AAP使用的胰岛素抵抗风险,导致代谢综合征,从而促进内皮功能障碍,导致CVD。因此,补充叶酸可能是一个现实的治疗选择,以减少AAP相关的心血管并发症。这项研究的成功完成将从根本上推进精神分裂症的治疗,因为我们了解更多与AAP相关代谢并发症相关的遗传,饮食和生活方式因素,以及测量该人群中内皮功能障碍的发生率,并确定潜在的改善因素,如补充叶酸,以减轻与AAP使用相关的总体心血管负担。公共卫生关系:这一建议将有助于临床医生更好地了解遗传、饮食和生活方式因素如何相互作用,使精神分裂症患者因非典型抗精神病药物使用而增加代谢综合征、胰岛素抵抗和内皮功能障碍的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VICKI L ELLINGROD其他文献
VICKI L ELLINGROD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VICKI L ELLINGROD', 18)}}的其他基金
CTSA Predoctoral T32 at the University of Michigan
CTSA 密歇根大学博士前 T32
- 批准号:
10620888 - 财政年份:2023
- 资助金额:
$ 33.42万 - 项目类别:
CTSA K12 Program at the University of Michigan
密歇根大学 CTSA K12 项目
- 批准号:
10621008 - 财政年份:2023
- 资助金额:
$ 33.42万 - 项目类别:
Development, Implementation and AssessMent of Novel Training in Domain-based Competencies (DIAMOND)
新型领域能力培训的开发、实施和评估(DIAMOND)
- 批准号:
9319951 - 财政年份:2017
- 资助金额:
$ 33.42万 - 项目类别:
Antipsychotic and Folate Pharmacogenetics - Gender Supplement
抗精神病药和叶酸药物遗传学 - 性别补充剂
- 批准号:
8797754 - 财政年份:2008
- 资助金额:
$ 33.42万 - 项目类别:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
叶酸药物基因组学和非典型抗精神病药代谢副作用的风险
- 批准号:
8019472 - 财政年份:2008
- 资助金额:
$ 33.42万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 33.42万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 33.42万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 33.42万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 33.42万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 33.42万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 33.42万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 33.42万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 33.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 33.42万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 33.42万 - 项目类别: